Stemcentrx
Develops innovative therapies for cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€9.3b (Public information from Apr 2016)
South San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$23.5m | Late VC | ||
$42.0m | Series D | ||
$200m | Series F | ||
$250m | Series G | ||
$10.2b Valuation: $10.2b | Acquisition | ||
Total Funding | €469m |
Related Content
Recent News about Stemcentrx
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.